Matt Teague and Jessica Taylor, lawyers from our firm, assisted in this trial. Read more
The FDA can only base its approval or denial on the information a drug manufacturer provides to them. Read more
The direct buyers argued that certification for the purposes of settlement is warranted considering the proposed class includes 35 members. Read more
The FDA study, which included 1,500 participants, showed that consumers were significantly more likely to recall risks and benefits. Read more
Lawyers in our firm’s Mass Torts Section are investigating claims on behalf of individuals and families injured by Invokana and Invokamet. Read more
Taxotere is a chemotherapy drug approved by the Food and Drug Administration (FDA) to treat breast cancer and other forms of cancer. Read more
The testosterone trial was still in progress when this issue went to the printer. Read more
We have previously reported that more than 5,800 Risperdal lawsuits are pending in the Philadelphia state court. Read more
Lawyers in the section are currently investigating cases involving Abilify and compulsive gambling. Read more
US Bioservices Corp. has agreed to pay $13.4M to settle claims that it engaged in a kickback scheme with Novartis to boost sales of Exjade. Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.